Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · Real-Time Price · USD
0.7136
+0.0046 (0.65%)
Apr 17, 2025, 4:00 PM EDT - Market closed
RVPH Stock Forecast
RVPH's stock price has decreased by -78.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for RVPH stock have an average target of 10, with a low estimate of 7.00 and a high estimate of 17. The average target predicts an increase of 1,301.35% from the current stock price of 0.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for RVPH stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 4 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 1 | 1 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 → $8 | Strong Buy | Maintains | $15 → $8 | +1,021.08% | Apr 1, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $11 | Strong Buy | Maintains | $14 → $11 | +1,441.48% | Jan 22, 2025 |
D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +2,002.02% | Jan 21, 2025 |
Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $7 | Hold → Strong Buy | Upgrades | $7 | +880.94% | Jan 10, 2025 |
Roth MKM | Roth MKM | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +880.94% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
n/a
from 282.38M
Revenue Next Year
n/a
EPS This Year
-0.82
from -0.90
EPS Next Year
-0.46
from -0.82
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.47 | -0.27 | -0.44 | ||
Avg | -0.82 | -0.46 | -0.43 | ||
Low | -0.98 | -0.69 | -0.41 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.